Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
Now available on-demand! Cracking the code: learnings from oligonucleotide method development WATCH NOW

Land O’Lakes: The case for trap and elute microflow LC (Rick King)

13 Oct 2015
Chromatography

In collaboration with the event organizers (University of Wisconsin), Bioanalysis Zone is pleased to feature a presentation by Rick King entitled ‘The case for trap and elute microflow’ from the 16th Annual Land O’Lakes Bioanalytical Conference, July 13-16 2015.

More presentations from the 16th  Land O’Lakes Bioanalytical Conference:

The use of blood microsampling for the quantitative bioanalysis of pharmaceuticals in early development (Roger Hayes)

Innovative methodologies for large molecule analysis in LC-MS/MS (Vincent Trinh)

A clinical case study of capillary microsampling (Tom Verhaeghe)

Related tags

LC microfluidics
Previous article Next article

Related articles

11 OCT 2012 EXPERT OPINION
Realising the potential of metabolomics
16 DEC 2024 JOURNAL ARTICLES
The fusion of microfluidics and artificial intelligence: a novel alliance for medical advancements
20 FEB 2014 CHROMATOGRAPHY
Interview with Irving W Wainer (NIH) on his career so far and the future of bioanalysis
1 MAY 2014 GENERAL INTEREST
Microfluidic device could allow faster stroke diagnosis
1 JUN 2015 GENERAL INTEREST
First microfluidic device capable of capturing clusters of circulating tumor cells developed
24 MAR 2020 BIOMARKERS
New tool uses microfluidic platform to perform cancer liquid biopsies
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone